5 Oversold Canadian Stocks To Buy

Page 5 of 5

1. Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Latest 14 Day RSI Score: 17.69

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) is a biotechnology firm developing treatments for prostate problems, tumors, and different kinds of cancers. The stock is rated Strong Buy on average and the latest ratings come from Wedbush and Raymond James which both maintained an Outperform rating on the stock in June 2023.

14 of the 943 hedge funds part of Insider Monkey’s Q1 2023 survey had held a stake in the firm. Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)’s largest shareholder out of these is David Witzke and Michael Gregory’s Avidity Partners Management with a $21.4 million stake.

Follow Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Disclosure: None. You can also take a look at 15 Most Valuable Canadian Companies and 15 High Growth Large Cap Stocks to Invest In.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5